64
Objective:  T o understand and explain the structure and activity relationship of each drug group  1 Analgesics and Anti-inflammatory drugs  613 352 Pharmaceutical Chemistry by Assist.Prof.Dr.Suthasinee T.  

1opioidc2011t2_632-634_v2

Embed Size (px)

Citation preview

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 1/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 2/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 3/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 4/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 5/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 6/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 7/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 8/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 9/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 10/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 11/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 13/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 14/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 15/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 16/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 17/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 18/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 19/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 20/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 21/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 22/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 23/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 24/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 25/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 26/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 27/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 28/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 29/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 30/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 31/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 32/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 33/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 34/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 35/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 36/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 37/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 38/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 39/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 40/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 41/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 42/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 43/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 44/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 45/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 46/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 47/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 48/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 49/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 50/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 51/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 52/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 53/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 54/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 55/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 56/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 57/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 58/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 59/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 60/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 61/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 62/64

7/28/2019 1opioidc2011t2_632-634_v2

http://slidepdf.com/reader/full/1opioidc2011t2632-634v2 63/64